ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)

ClinicalTrials.gov ID: NCT04603937

Public ClinicalTrials.gov record NCT04603937. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 11:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Visual Impairment Secondary to Treatment-naïve Diabetic Macular Edema (DME)

Study identification

NCT ID
NCT04603937
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kodiak Sciences Inc
Industry
Enrollment
459 participants

Conditions and interventions

Interventions

  • Aflibercept Drug
  • KSI-301 Drug
  • Sham Procedure Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 29, 2020
Primary completion
Apr 26, 2023
Completion
Aug 30, 2023
Last update posted
Aug 21, 2024

2020 – 2023

United States locations

U.S. sites
40
U.S. states
19
U.S. cities
40
Facility City State ZIP Site status
Retinal Research Institute, LLC Phoenix Arizona 85014
Retina Vitreous Associates Beverly Hills California 90211
Retina Consultants of Orange County Fullerton California 92835
Northern California Retina Vitreous Associates Mountain View California 94040
Retina Consultants of San Diego Poway California 92064
Retinal Consultants Medical Group Inc Sacramento California 95825
Retina Group of New England Waterford Connecticut 06385
Florida Eye Microsurgical Institute Boynton Beach Florida 33426
Rand Eye Institute Deerfield Beach Florida 33064
National Ophthalmic Research Institute Fort Myers Florida 33912
Fort Lauderdale Eye Institute Plantation Florida 33324
Retina Vitreous Associates of Florida St. Petersburg Florida 33703
Southern Vitreoretinal Associates Tallahassee Florida 32308
Southeast Retina Center Augusta Georgia 30909
Georgia Retina, P.C. Marietta Georgia 30060
Retina Consultants of Hawaii, Inc ‘Aiea Hawaii 96701
Retina Specialists of Idaho Boise Idaho 83713
Talley Eye Evansville Indiana 47710
Maine Eye Center Portland Maine 04101
Associated Retinal Consultants PC Royal Oak Michigan 48073
Vitreoretinal Surgery PA Minneapolis Minnesota 55435
Retina Consultants of NV Henderson Nevada 89052
Sierra Eye Associates Reno Nevada 89502
Vitreo Retinal Consultants Hauppauge New York 11788
Retina-Vitreous Surgeons of Central NY Liverpool New York 13088
Ophthalmic Consultants of Long Island Oceanside New York 11572
Retina Associates of Western NY Rochester New York 14620
Asheville Eye Associates Asheville North Carolina 28803
Cleveland Clinic Foundation, Cole Eye Institute Cleveland Ohio 44195
Retina Consultants, LLC Salem Oregon 97302
Southeastern Retina Associates PC Knoxville Tennessee 37922
Retina Research Institute of Texas Abilene Texas 79606
Austin Research Center for Retina Austin Texas 78705
Texas Retina Associates Fort Worth Texas 76108
Retina Consultants of Houston-(Katy) Katy Texas 77494
Texas Retina Associates Plano Texas 75075
Austin Retina Associates (Round Rock) Round Rock Texas 78681
Medical Center Ophthalmology Associates San Antonio Texas 78240
Retina Consultants of Houston - (Woodlands) The Woodlands Texas 77384
Retina Institute of Virginia Richmond Virginia 23235

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04603937, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2024 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04603937 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →